A Phase Ⅲ Clinical Study of SNA02-48 Injection
A Phase Ⅲ Clinical Study of SNA02-48 Injection
Not yet recruiting · NCT07633119 · Registry updated 2026-06-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase Ⅲ Clinical Study of SNA02-48 Injection | Bacterial Infections and Mycoses, Clostridium infectious disease, Infections, bacterial infectious disease, gram-positive bacterial infections, tetanus | Not yet recruiting | Phase 3 | 2026-06-08 | NCT07633119 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sinovac Life Sciences Co., Ltd. | 8 |
30 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.